0001140361-21-021772.txt : 20210621
0001140361-21-021772.hdr.sgml : 20210621
20210621180024
ACCESSION NUMBER: 0001140361-21-021772
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cherington Charles
CENTRAL INDEX KEY: 0001448698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11460
FILM NUMBER: 211032266
MAIL ADDRESS:
STREET 1: ONE BOW STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc.
CENTRAL INDEX KEY: 0000748592
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 311103425
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 140 58TH STREET, BUILDING A
STREET 2: SUITE 2100
CITY: BROOKLYN
STATE: NY
ZIP: 11220
BUSINESS PHONE: (212) 582-1199
MAIL ADDRESS:
STREET 1: 140 58TH STREET, BUILDING A
STREET 2: SUITE 2100
CITY: BROOKLYN
STATE: NY
ZIP: 11220
FORMER COMPANY:
FORMER CONFORMED NAME: NTN BUZZTIME INC
DATE OF NAME CHANGE: 20051230
FORMER COMPANY:
FORMER CONFORMED NAME: NTN COMMUNICATIONS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: ALROY INDUSTRIES INC
DATE OF NAME CHANGE: 19850411
4
1
form4.xml
FORM 4
X0306
4
2021-06-16
0000748592
Brooklyn ImmunoTherapeutics, Inc.
BTX
0001448698
Cherington Charles
C/O BROOKLYN IMMUNOTHERAPEUTICS, INC.
140 58TH STREET, BUILDING A, SUITE 2100
BROOKLYN
NY
11220
true
true
Common Stock
2021-06-16
4
S
0
200000
15.7338
D
6094101
D
Common Stock
2021-06-17
4
S
0
198000
15.7435
D
5896101
D
Common Stock
2021-06-17
4
S
0
2000
16.2974
D
5894101
D
The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.53 to $16.11, inclusive.
The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.25 to $16.24, inclusive.
The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.25 to $16.35, inclusive.
The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 through 3 to this Form 4.
/s/ Mark L. Johnson, Attorney-in-Fact for Charles Cherington
2021-06-21